1. Home
  2. PWM vs AXDX Comparison

PWM vs AXDX Comparison

Compare PWM & AXDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PWM
  • AXDX
  • Stock Information
  • Founded
  • PWM 2018
  • AXDX 1982
  • Country
  • PWM Hong Kong
  • AXDX United States
  • Employees
  • PWM N/A
  • AXDX N/A
  • Industry
  • PWM
  • AXDX Biotechnology: Laboratory Analytical Instruments
  • Sector
  • PWM
  • AXDX Industrials
  • Exchange
  • PWM Nasdaq
  • AXDX Nasdaq
  • Market Cap
  • PWM 34.6M
  • AXDX 28.3M
  • IPO Year
  • PWM 2023
  • AXDX 1996
  • Fundamental
  • Price
  • PWM $0.70
  • AXDX $1.19
  • Analyst Decision
  • PWM
  • AXDX Hold
  • Analyst Count
  • PWM 0
  • AXDX 1
  • Target Price
  • PWM N/A
  • AXDX $1.00
  • AVG Volume (30 Days)
  • PWM 1.3M
  • AXDX 31.2K
  • Earning Date
  • PWM 02-13-2025
  • AXDX 03-27-2025
  • Dividend Yield
  • PWM N/A
  • AXDX N/A
  • EPS Growth
  • PWM N/A
  • AXDX N/A
  • EPS
  • PWM N/A
  • AXDX N/A
  • Revenue
  • PWM $639,912.00
  • AXDX $11,909,000.00
  • Revenue This Year
  • PWM N/A
  • AXDX $0.66
  • Revenue Next Year
  • PWM N/A
  • AXDX $3.36
  • P/E Ratio
  • PWM N/A
  • AXDX N/A
  • Revenue Growth
  • PWM N/A
  • AXDX N/A
  • 52 Week Low
  • PWM $0.45
  • AXDX $0.73
  • 52 Week High
  • PWM $2.70
  • AXDX $2.09
  • Technical
  • Relative Strength Index (RSI)
  • PWM 36.58
  • AXDX 46.90
  • Support Level
  • PWM $0.50
  • AXDX $1.07
  • Resistance Level
  • PWM $1.27
  • AXDX $1.22
  • Average True Range (ATR)
  • PWM 0.35
  • AXDX 0.10
  • MACD
  • PWM -0.07
  • AXDX -0.01
  • Stochastic Oscillator
  • PWM 11.07
  • AXDX 41.38

About PWM Prestige Wealth Inc.

Prestige Wealth Inc is engaged in providing private wealth management services and asset management to high-net-worth and ultra-high-net-worth individuals and enterprises through its subsidiaries.

About AXDX Accelerate Diagnostics Inc.

Accelerate Diagnostics Inc is an in vitro diagnostics company that specializes in rapid diagnostics for infectious pathogens. The firm's core platform, the Accelerate ID/AST System, determines whether live bacterial or fungal cells in a patient sample are susceptible to a particular antibiotic. This test is performed on pathogens that are commonly associated with serious infections and can deliver results more quickly than traditional methods, such as bacterial culturing. The system can analyze a positive blood culture sample in approximately five hours, which is faster than traditional testing techniques. The company earns majority of its revenue from domestic market.

Share on Social Networks: